Merrimack Pharmaceuticals | 15-12G:终止注册
Merrimack Pharmaceuticals | 10-Q:季度报表
Merrimack Pharmaceuticals | 25:注销已到期、已赎回、已兑付证券的通知
Merrimack Pharmaceuticals | 8-K:重大事件
Merrimack Pharmaceuticals | DEFA14A:其他
Merrimack Pharmaceuticals | 8-K:重大事件
Merrimack Pharmaceuticals | DEFA14A:其他
Merrimack Pharmaceuticals | 8-K:重大事件
Merrimack Pharmaceuticals | DEFR14A:修正后委托征集材料
Merrimack Pharmaceuticals | DEFA14A:其他
Merrimack Pharmaceuticals | 8-K:重大事件
Merrimack Pharmaceuticals | DEFA14A:其他
Merrimack Pharmaceuticals | DEF 14A:股东委托书决议
Merrimack Pharmaceuticals | 10-K/A:年度报表(修正版)
Merrimack Pharmaceuticals | 425:募资说明/企业合并公告
Merrimack Pharmaceuticals | 8-K:重大事件
Merrimack Pharmaceuticals | 10-K:年度报表
Merrimack Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.99%)
Merrimack Pharmaceuticals | PRE 14A:并购重组委托声明
Merrimack Pharmaceuticals | SCHEDULE 13G:其他
暂无数据